Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,133 | 0,146 | 19:35 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.04. | Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024 | 312 | ACCESSWIRE | PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCECTC HER2 assay being developed for HER2 targeted drugs and antibody drug conjugates presented at internationally renowned... ► Artikel lesen | |
22.03. | Angle PLC Announces Parsortix at European Breast Cancer Conference | 258 | ACCESSWIRE | PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCEANGLE presenting two posters highlighting the utility of the Company's new Portrait+ CTC Staining Kit and Portrait... ► Artikel lesen | |
22.01. | IN BRIEF: Angle highlights supportive data for DNA analysis tool | 1 | Alliance News | ||
22.01. | Angle PLC Announces Potential Utility in Precision Oncology | 275 | ACCESSWIRE | REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGYPaper published in the journal "Current Issues in Molecular Biology" special issue: advanced... ► Artikel lesen | |
10.01. | Angle PLC Announces Standard Form for Notification of Major Holdings | 297 | ACCESSWIRE | GUILDFORD, SURREY / ACCESSWIRE / January 10, 2024 / ANGLE plc:TR-1: Standard form for notification of major holdings:NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA... ► Artikel lesen | |
04.01. | Angle shares soar following "breakthrough" cancer diagnostics results | 2 | Alliance News | ||
04.01. | AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up | 2 | Alliance News | ||
04.01. | Angle receives 'breakthrough results' from DNA molecular analysis | 3 | Sharecast | ||
04.01. | Angle PLC Announces Breakthrough Clinical Results | 235 | ACCESSWIRE | BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCERCombined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample highlights potential... ► Artikel lesen | |
02.01. | Angle locks in $250,000 contract with Eisai | 4 | Sharecast | ||
02.01. | IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial | 3 | Alliance News | ||
02.01. | ANGLE Plc Signs Contract With Eisai | 3 | RTTNews | ||
02.01. | Angle PLC - Contract announcement with Eisai Inc. | 490 | ACCESSWIRE | Pilot study for ANGLE's Portrait HER2 assay in Phase II study of HER2 targeting antibody-drug conjugate, BB-1701GUILDFORD, SURREY / ACCESSWIRE / January 2, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a... ► Artikel lesen | |
11.12.23 | Angle PLC Announces Broker Announcement | 239 | ACCESSWIRE | GUILDFORD, SURREY / ACCESSWIRE / December 11, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use... ► Artikel lesen | |
11.12.23 | Angle PLC Announces Parsortix Unlocks Opportunities for Drug Discovery | 238 | ACCESSWIRE | USE OF PARSORTIX SYSTEM IN PRE-CLINICAL MODEL UNLOCKS OPPORTUNITIES FOR DRUG DISCOVERYHarvested CTCs reveal gene expression profile associated with development and progression of brain metastasis in... ► Artikel lesen | |
05.12.23 | IN BRIEF: Angle launches diagnostic kit at cancer symposium | 2 | Alliance News | ||
05.12.23 | ANGLE plc: ANGLE launches Portrait+ CTC kit at SABCS | 312 | ACCESSWIRE | ANGLE LAUNCHES PORTRAIT+ CTC KIT AT SAN ANTONIO BREAST CANCER SYMPOSIUMANGLE's Portrait+ CTC staining kit combines the power of Parsortix® technology with an optimised immunofluorescent assayThe test... ► Artikel lesen | |
09.11.23 | Angle says build up of revenue slower than hoped; launches test | 3 | Alliance News | ||
09.11.23 | Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies | 157 | ACCESSWIRE | ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIESANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to investigate real-time patient PD-L1 status for clinical studiesThe... ► Artikel lesen | |
09.11.23 | Angle PLC Announces Trading and Business Update | 186 | ACCESSWIRE | Revenue recognised for 2023 expected to be up 120% at c. £2.2 million with sales secured in 2023 expected to be c. £3.3 millionRevenue recognised for 2024 expected to treble compared to 2023Cash runway... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CHINA WATER | 0,589 | +0,86 % | Dividendenbekanntmachungen (29.01.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) APOGEE ENTERPRISES INC US0375981091 0,25 USD 0,2303 EUR AZZ INC US0024741045 0,17 USD 0,1566 EUR BANK OF MONTREAL CA0636711016 1... ► Artikel lesen | |
SGS | 84,60 | +0,61 % | Dividendenbekanntmachungen (02.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BANCO BRADESCO SA BRBBDCACNPR8 0,0189 BRL 0,0035 EUR BANCO BRADESCO SA ADR US0594604029 0,0034 USD 0,0032 EUR BANCO BRADESCO SA... ► Artikel lesen | |
SAGE GROUP | 13,300 | -0,37 % | Sage Group Q1 Revenue Climbs | NEWCASTLE UPON TYNE (dpa-AFX) - Sage Group Plc (SGE.L), an accounting, financial, HR and payroll technology company, reported Thursday that its first-quarter total revenue grew 10 percent to... ► Artikel lesen | |
AMERICAN CANNABIS | 0,060 | -100,00 % | American Cannabis Company, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | ||
FLUENT | 2,570 | +0,78 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 12.04.2024 | The following instruments on XETRA do have their first trading 12.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.04.2024
Aktien
1 US0412321095 Arkema S.A. ADR
2 US60342R1014... ► Artikel lesen | |
AAR | 58,50 | -1,27 % | AAR CORP.: AAR signs extension and expansion of V2500 engine component distribution agreement with Sumitomo Precision Products | WOOD DALE, Ill., April 11, 2024 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has signed an extension and... ► Artikel lesen | |
ADT | 5,800 | 0,00 % | ADT Inc. - 8-K, Current Report | ||
BEFESA | 33,000 | -5,66 % | Befesa-Aktie heute am Aktienmarkt kaum gefragt: Kurs fällt (35,42 €) | Die Befesa-Aktie notiert heute etwas leichter. Das Wertpapier notiert gegenwärtig bei 35,42 Euro. Im deutschen Wertpapierhandel hat sich heute die Aktie von Befesa zwischenzeitlich um 3,17 Prozent verbilligt.... ► Artikel lesen | |
STROEER | 58,60 | -0,51 % | Ströer-Aktie verliert 3,70 Prozent (55,90 €) | Im Minus liegt aktuell die Ströer-Aktie . Das Papier notiert derzeit bei 55,90 Euro. Jahreschart der Ströer-Aktie, Stand 16.04.2024 Eine Verbilligung in Höhe von 2,15 Euro müssen derzeit die Aktionäre... ► Artikel lesen | |
CORVEL | 228,59 | -0,28 % | CorVel Corp.: CorVel Announces Revenues and Earnings | FORT WORTH, Texas, Jan. 30, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2023. Revenues for the quarter were $202 million, an... ► Artikel lesen | |
TARGET HOSPITALITY | 11,010 | +1,19 % | Jason P. Vlacich Implements A Sell Strategy: Offloads $582K In Target Hospitality Stock | ||
AMADEUS FIRE | 116,00 | 0,00 % | WARBURG RESEARCH stuft AMADEUS FIRE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat die Einstufung für Amadeus Fire vor Zahlen zum ersten Quartal auf "Buy" mit einem Kursziel von 180 Euro belassen. Einige Wettbewerber... ► Artikel lesen | |
PURECYCLE TECHNOLOGIES | 5,115 | +0,20 % | PureCycle Technologies, Inc.: Scheduled Operational Pause at Ironton Purification Facility to Begin in April | IRONTON, OH / ACCESSWIRE / March 28, 2024 / PureCycle Technologies, Inc. (NASDAQ:PCT), today, announced that its flagship purification facility in Ironton, Ohio will begin a scheduled operational pause... ► Artikel lesen | |
WASTE MANAGEMENT | 194,48 | +0,96 % | Waste Management (WM) to Report Q1 Earnings: What's in Store? | ||
SNAP-ON | 251,30 | +2,20 % | Aktienmarkt: Kurs der Aktie von Snap-On im Minus (265,2270 €) | Am US-amerikanischen Aktienmarkt liegt die Aktie von Snap-On zur Stunde im Minus. Das Wertpapier kostete zuletzt 281,87 US-Dollar. An der Börse liegt der Anteilsschein von Snap-On gegenwärtig im Minus.... ► Artikel lesen |